Role of prenatal ultrasonography in women with positive screen for Down syndrome on the basis of maternal serum markers
- PMID: 7485289
- DOI: 10.1016/0002-9378(95)91322-x
Role of prenatal ultrasonography in women with positive screen for Down syndrome on the basis of maternal serum markers
Abstract
Objective: Our purpose was to evaluate the usefulness of prenatal ultrasonography among women with a positive screen for fetal Down syndrome on the basis of three biochemical markers--maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol.
Study design: A total of 395 women underwent prenatal ultrasonography at a single institution after being identified as screen positive (midtrimester risk > or = 1:195) on the basis of triple-marker screening between 15 and 18 weeks. Ultrasonographic findings were compared with the biochemical markers and the eventual fetal outcome for these patients. Ultrasonographic abnormalities that were evaluated included structural defects, nuchal thickening or cystic hygroma, echogenic bowel, cerebral ventricular dilatation, pyelectasis, and shortened femur.
Results: Among 395 patients, 374 (94.7%) had normal karyotype by genetic amniocentesis (n = 232) or postnatal follow-up (n = 142), 18 (4.5%) proved to have Down syndrome, and three had other karyotypic abnormalities. One or more ultrasonographic abnormalities were found in nine of 18 (50%) with Down syndrome compared to 27 of 377 (7.2%) other fetuses (p < 0.001). Fetuses with abnormal ultrasonography results included three with other chromosome abnormalities and five with nonchromosomal anomalies. An abnormal ultrasonography result increased the risk of Down syndrome by 5.6-fold (25% from 4.5%) and a negative result reduced the risk by 45% (2.5% from 4.5%). The value of ultrasonography is further enhanced when all chromosome abnormalities and nonchromosomal anomalies are considered.
Conclusion: Abnormal ultrasonographic findings increase the risk for Down syndrome, whereas normal findings are less predictive of normalcy. After correction for inaccurate menstrual dates, genetic amniocentesis should be offered in spite of a normal ultrasonography result among women with positive triple screen.
Similar articles
-
Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study.Am J Obstet Gynecol. 1995 Oct;173(4):1306-9. doi: 10.1016/0002-9378(95)91376-9. Am J Obstet Gynecol. 1995. PMID: 7485343 Clinical Trial.
-
Choroid plexus cysts: Is biochemical testing a valuable adjunct to targeted ultrasonography?Am J Obstet Gynecol. 1999 Aug;181(2):260-5. doi: 10.1016/s0002-9378(99)70545-4. Am J Obstet Gynecol. 1999. PMID: 10454666
-
Prenatal diagnosis of diverse chromosome abnormalities in a population of patients identified by triple-marker testing as screen positive for Down syndrome.Am J Obstet Gynecol. 1995 Aug;173(2):496-501. doi: 10.1016/0002-9378(95)90272-4. Am J Obstet Gynecol. 1995. PMID: 7544068
-
[Prenatal diagnosis of trisomy 21].Ann Biol Clin (Paris). 1990;48(8):536-40. Ann Biol Clin (Paris). 1990. PMID: 1705107 Review. French.
-
Prospective evaluation of prenatal maternal serum screening for trisomy 18.Am J Obstet Gynecol. 1998 Mar;178(3):446-50. doi: 10.1016/s0002-9378(98)70418-1. Am J Obstet Gynecol. 1998. PMID: 9539506 Review.
Cited by
-
Prenatal Aneuploidies Computerized Screening (SCA TEST): a pilot study on 1000 women.J Prenat Med. 2007 Oct;1(4):47-56. J Prenat Med. 2007. PMID: 22470829 Free PMC article.
-
Early amniocentesis as a method of choice in diagnosing gynecological diseases.Acta Inform Med. 2013 Dec;21(4):270-3. doi: 10.5455/aim.2013.21.270-273. Epub 2013 Dec 4. Acta Inform Med. 2013. PMID: 24554804 Free PMC article.
-
Ultrasonographic soft markers of aneuploidy in second trimester: are we lost?MedGenMed. 2006 Jan 11;8(1):9. MedGenMed. 2006. PMID: 16915139 Free PMC article. Review.
-
Influence of second-trimester ultrasound markers for Down syndrome in pregnant women of advanced maternal age.J Pregnancy. 2014;2014:785730. doi: 10.1155/2014/785730. Epub 2014 Mar 25. J Pregnancy. 2014. PMID: 24795825 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical